Drugs / Donor CD34+
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05806749 Background | Jul 2023 → Aug 2028 expected | chronic transplant rejection, end stage renal failure | University of California, Los Angeles | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor CD34+ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05806749 ↗ |
| Modality | Cell therapy | “An infusion of at least 8 X106 donor CD34 cells/kg recipient weight” NCT05806749 ↗ |